News

See the latest Enterprise Products Partners LP stock price (EPD:XNYS), related news, valuation, dividends and more to help you make your investing decisions.
Eli Lilly's lepodisiran has been shown to reduce Lp (a) levels by more than 90% for at least six months with a single injection in a phase 2 trial.
See the latest Brookfield Renewable Partners LP stock price (BEP:XNYS), related news, valuation, dividends and more to help you make your investing decisions.
It is playing catch-up with a rival Lp (a) targeting antisense drug from Novartis and development partner Akcea, called pelacarsen, which is already in a phase 3 trial called HORIZON with major ...
Find the latest Energy Transfer LP (ET) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.